October 20, 2016 8:56 PM ET


Company Overview of Cosmo Pharmaceuticals N.V.

Executive Profile

Alessandro E. Della Chà LL.M

Chief Executive Officer and Executive Director, Cosmo Pharmaceuticals N.V.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Alessandro E. Della Chà, LLM, has been the Chief Executive Officer of Cosmo Pharmaceuticals N.V. (formerly Cosmo Pharmaceuticals S.p.A) since March 27, 2014 and also has been its Executive Director since 2006. Mr. Chà served as a Senior Partner at Studio Legale Edoardo Ricci e Associati, Milan until March 27, 2014. He specialized in company law, mergers and acquisitions. He joined the Studio Legale Edoardo Ricci e Associati in 1988. He served as an Assistant of the ...

Corporate Headquarters

Amsterdam, Noord-Holland --


Phone: --
Fax: --

Board Members Memberships

Chief Executive Officer and Executive Director


Master's Degree
University of Leicester
Universita' degli Studi di Milano

Other Affiliations

Annual Compensation

Total Annual Compensation€3,997,945

Stocks Options

Unexercisable Options€105,000
Total Number of Options€105,000

Total Compensation

Total Annual Cash Compensation€3,997,945
Total Short Term Compensation€3,997,945
Total Calculated Compensation€5,000,963

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
James A. Schoeneck Chief Executive Officer, President and Director
Depomed, Inc.
Jack A. Khattar Founder, Chief Executive Officer, President, Secretary and Director
Supernus Pharmaceuticals, Inc.
Craig A. Collard Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cosmo Pharmaceuticals N.V., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.